Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03575897 · ClinicalTrials.gov registry record · NA

Serial Assessment of Body Fat Accrual in Very Preterm Infants

A NA study of Body Weight and Adiposity, sponsored by University of Alabama at Birmingham.

Active
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT03575897 is a NA study of Body Weight and Adiposity that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 50 participants, below the 282-participant average among 23 other Body Weight trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03575897, a NA study of Body Weight and Adiposity, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Despite evidence that both rapid weight gain and excessive body fat accrual are associated with overweight and obesity, usual neonatal care of preterm infants does not include assessment of body fat accrual. The study hypothesis is that identification of early changes in infant body composition (i.e. amount of fat mass and fat-free mass) reduces % body fat at 3 months of age.

Interventions

  • DIAGNOSTIC_TEST Assessment of infant body composition

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2018-09-10
Est. Completion 2026-12
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT03575897

The ClinicalTrials.gov registry entry for NCT03575897 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 282-participant average among 23 other Body Weight trials with a reported enrollment target (82% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Body Weight appearing as the primary indexed condition, and to 1 intervention - of which Assessment of infant body composition is the first listed.

NCT03575897 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT03575897 about?

NCT03575897 is a clinical study titled "Serial Assessment of Body Fat Accrual in Very Preterm Infants". Despite evidence that both rapid weight gain and excessive body fat accrual are associated with overweight and obesity, usual neonatal care of preterm infants does not include assessment of body fat accrual. The study hypothesis is that identification of early changes in infant body composition (i.e...

What is the current status of trial NCT03575897?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2018-09-10. Estimated completion is 2026-12.

What conditions does trial NCT03575897 study?

This clinical trial studies the following conditions: Body Weight, Adiposity, Infant,Premature.

What interventions are being tested in trial NCT03575897?

The interventions under investigation include: Assessment of infant body composition (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03575897?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03575897 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Body Weight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.